NCT01313741

Brief Summary

Two hundred patients will be analyzed both clinically (via validated outcomes measures) and radiographically (via 2 sets of standard radiographs) to determine the survival and degree of bone in growth of a novel all polyethelene glenoid component used in a standard FDA approved shoulder arthroplasty system.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Apr 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 14, 2011

Completed
18 days until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

March 14, 2011

Status Verified

March 1, 2011

Enrollment Period

1 year

First QC Date

March 10, 2011

Last Update Submit

March 10, 2011

Conditions

Outcome Measures

Primary Outcomes (3)

  • ASES Scores

    Accepted validated clinical outcome measure

    Every 3 months

  • PENN Score

    Accepted validated outcome measure

    3 months

  • Radiographic integration of component

    Two sets of radiographs will be obtained to look for any signs of loosening and for bony integration of the component

    2 weeks, 6 weeks, 3 months, 2 years

Study Arms (1)

Single arm shoulder arthroplasty

EXPERIMENTAL
Device: Shoulder arthroplasty with anchor peg glenoid

Interventions

Shoulder arthroplasty with anchor peg glenoid

Single arm shoulder arthroplasty

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Knoxville Orthopaedic Clinic

Knoxville, Tennessee, 37922, United States

Location

Related Links

Central Study Contacts

Edwin E Spencer Jr, MD

CONTACT

Jeff G Jarnigan, PA

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 10, 2011

First Posted

March 14, 2011

Study Start

April 1, 2011

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

March 14, 2011

Record last verified: 2011-03

Locations